(Q34228973)

31 July 2017

1 reference

title

ADME-Tox in drug discovery: integration of experimental and computational technologies (English)

1 reference

31 July 2017

1 reference

Hongshi Yu

1

1 reference

31 July 2017

Adedayo Adedoyin

series ordinal

2

1 reference

31 July 2017

publication date

1 September 2003

1 reference

31 July 2017

1 reference

31 July 2017

volume

8

1 reference

31 July 2017

issue

18

1 reference

31 July 2017

page(s)

852-861

1 reference

Risks in new drug development: approval success rates for investigational drugs

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902828-9

7 January 2021

ADME/PK as part of a rational approach to drug discovery

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902828-9

7 January 2021

High-throughput approaches for evaluating absorption, distribution, metabolism and excretion properties of lead compounds

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902828-9

7 January 2021

Pharmacokinetics and metabolism in early drug discovery

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902828-9

7 January 2021

In vitro preclinical lead optimisation technologies (PLOTs) in pharmaceutical development

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902828-9

7 January 2021

The role of absorption, distribution, metabolism, excretion and toxicity in drug discovery

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902828-9

7 January 2021

Comparative study of the metabolism of drug substrates by human cytochrome P450 3A4 expressed in bacterial, yeast and human lymphoblastoid cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902828-9

7 January 2021

Comparative studies on in vitro methods for evaluating in vivo function of MDR1 P-glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902828-9

7 January 2021

Optimization of metabolic stability as a goal of modern drug design

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902828-9

7 January 2021

Recent advances in use of LC/MS/MS for quantitative high-throughput bioanalytical support of drug discovery

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902828-9

7 January 2021

Application of parallel liquid chromatography/mass spectrometry for high throughput microsomal stability screening of compound libraries

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902828-9

7 January 2021

Microtiter plate assays for inhibition of human, drug-metabolizing cytochromes P450

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902828-9

7 January 2021

A high-throughput screening method for the determination of aqueous drug solubility using laser nephelometry in microtiter plates

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902828-9

7 January 2021

High throughput physicochemical profiling for drug discovery

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902828-9

7 January 2021

Pharmaceutical profiling in drug discovery

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902828-9

7 January 2021

Progress in predicting human ADME parameters in silico

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902828-9

7 January 2021

The emerging importance of predictive ADME simulation in drug discovery

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902828-9

7 January 2021

Predicting ADME properties in silico: methods and models

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902828-9

7 January 2021

In silico prediction of ADME and pharmacokinetics. Report of an expert meeting organised by COST B15.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902828-9

7 January 2021

ADMET in silico modelling: towards prediction paradise?

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902828-9

7 January 2021

Towards a new age of virtual ADME/TOX and multidimensional drug discovery

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902828-9

7 January 2021

Computational methods for the prediction of 'drug-likeness'

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902828-9

7 January 2021

Development of quantitative structure-property relationship models for early ADME evaluation in drug discovery. 1. Aqueous solubility

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902828-9

7 January 2021

Development of quantitative structure-property relationship models for early ADME evaluation in drug discovery. 2. Blood-brain barrier penetration.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902828-9

7 January 2021

Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 1. Prediction of intestinal absorption

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902828-9

7 January 2021

Evaluation of human intestinal absorption data and subsequent derivation of a quantitative structure-activity relationship (QSAR) with the Abraham descriptors.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902828-9

7 January 2021

Computational models for cytochrome P450: a predictive electronic model for aromatic oxidation and hydrogen atom abstraction

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902828-9

7 January 2021

Ab initio molecular modeling in the study of drug metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902828-9

7 January 2021

Predicting the rates and regioselectivity of reactions mediated by the P450 superfamily

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902828-9

7 January 2021

Computation of the physio-chemical properties and data mining of large molecular collections

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902828-9

7 January 2021

Beyond mere diversity: tailoring combinatorial libraries for drug discovery

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902828-9

7 January 2021

The impact of informatics and computational chemistry on synthesis and screening

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902828-9

7 January 2021

Screening for human ADME/Tox drug properties in drug discovery

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902828-9

7 January 2021

In silico ADME/Tox: the state of the art.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902828-9

7 January 2021

Computer systems for the prediction of xenobiotic metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902828-9

7 January 2021

Role of ADME characteristics in drug discovery and their in silico evaluation: in silico screening of chemicals for their metabolic stability

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902828-9

7 January 2021

Strategies for absorption screening in drug discovery and development

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902828-9

7 January 2021

Assessing the absorption of new pharmaceuticals

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902828-9

7 January 2021

Current methodologies used for evaluation of intestinal permeability and absorption

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902828-9

7 January 2021

Prediction of intestinal absorption: comparative assessment of GASTROPLUS and IDEA.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902828-9

7 January 2021

Prediction of intestinal permeability

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902828-9

7 January 2021

ADME evaluation. 2. A computer model for the prediction of intestinal absorption in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902828-9

7 January 2021

Metabolic stability for drug discovery and development: pharmacokinetic and biochemical challenges

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902828-9

7 January 2021

Application of in silico approaches to predicting drug--drug interactions

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902828-9

7 January 2021

Progress and limitations in the use of in vitro cell cultures to serve as a permeability screen for the blood-brain barrier

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902828-9

7 January 2021

Predicting blood-brain barrier permeability of drugs: evaluation of different in vitro assays

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902828-9

7 January 2021

High throughput artificial membrane permeability assay for blood-brain barrier.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902828-9

7 January 2021

Recent advances in the prediction of blood-brain partitioning from molecular structure.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902828-9

7 January 2021

Predicting plasma protein binding of drugs: a new approach

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902828-9

7 January 2021

Web resources for drug toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902828-9

7 January 2021

The integration of data on physico-chemical properties, in vitro-derived toxicity data and physiologically based kinetic and dynamic as modelling a tool in hazard and risk assessment. A commentary.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902828-9

7 January 2021

Validation of the SOS/umu test using test results of 486 chemicals and comparison with the Ames test and carcinogenicity data

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902828-9

7 January 2021

10.1016/S1359-6446(03)02828-9

Identifiers

DOI

1 reference

31 July 2017

1 reference